A digital test that will help to provide a faster diagnosis for people with attention deficit hyperactivity disorder (ADHD) should be used by the NHS, according to draft guidance from NICE.
An artificial intelligence-powered blood test that may be able to predict Parkinson’s disease several years before symptoms start to develop could allow earlier treatment and help guide the
Roche’s move into the digital pathology category has been boosted by FDA approval of a lab instrument and toolkit for use as an aid to clinical diagnosis.
A new technology developed in the UK could make it possible to detect cancer at an early stage, long before the formation of a lump, by investigating the stiffness of indi
A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh